FORWARD1: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women with Folate Receptor Alpha - Positive
Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
The LION trial randomized 650 patients with
advanced epithelial ovarian cancer and macroscopic complete resection to either systematic pelvic and para-aortic LNE (323 patients in intention - to - treat cohort), or no LNE (324 patients in intention - to - treat cohort).
The sixteen chapters of
Advances in
Ovarian Cancer Management present a concise, timely and comprehensive overview on the current status of the etiology, diagnosis and treatment of women with epithelial ovarian
Ovarian Cancer Management present a concise, timely and comprehensive overview on the current status of the etiology, diagnosis and treatment of women with epithelial ovarian c
Cancer Management present a concise, timely and comprehensive overview on the current status of the etiology, diagnosis and treatment of women with
epithelial ovarian ovarian cancercancer.